PAA 8.89% 20.5¢ pharmaust limited

Ann: PharmAust makes Head of Manufacturing appointment, page-9

  1. 2,494 Posts.
    lightbulb Created with Sketch. 1414
    Hi @Bouncing
    The next trial that will start later this year, is an adaptive 2/3 trial for which the FDA has already advised they will consider accelerated approval at the 24 week mid trial results. This I understand is reliant on gaining Orphan Drug Designation status. The shelf life is also considerable so making a bulk batch will not go to waste.

    Cheers
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.5¢
Change
-0.020(8.89%)
Mkt cap ! $81.16M
Open High Low Value Volume
20.0¢ 21.0¢ 19.5¢ $331.9K 1.617M

Buyers (Bids)

No. Vol. Price($)
4 440882 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 12736 3
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.